Overview FACTO Study (Foster® As Complete Treatment Option) Status: Completed Trial end date: 2010-12-01 Target enrollment: Participant gender: Summary Double blind, multinational, multicentre, randomised, 2 arm parallel group study Phase: Phase 4 Details Lead Sponsor: Chiesi Farmaceutici S.p.A.Treatments: BeclomethasoneFluticasoneFluticasone Propionate, Salmeterol Xinafoate Drug CombinationFluticasone-Salmeterol Drug CombinationFormoterol FumarateSalmeterol Xinafoate